Torthaí cuardaigh - Per‐Uno Malmström

Beachtaigh na torthaí
  1. 1
    EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides

    EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides de réir Jörgen Carlsson, Kenneth Wester, Manuel de la Torre, Per‐Uno Malmström, Truls Gårdmark

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome

    Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome de réir Artur Mezheyeuski, Ulrika Segersten, Lina Leiss, Per‐Uno Malmström, Jiřı́ Hatina, Arne Östman, Carina Strell

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    <i>AdCD40L</i> Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial

    <i>AdCD40L</i> Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial de réir Per‐Uno Malmström, Angelica Loskog, Camilla A. Lindqvist, Sara M. Mangsbo, Moa Fransson, Alkwin Wanders, Truls Gårdmark, Thomas H. Tötterman

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

    Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer de réir Karolina Boman, Anna Larsson, Ulrika Segersten, Eugenia Kuteeva, Henrik Johannesson, Björn Nodin, Jakob Eberhard, Mathias Uhlén, Per‐Uno Malmström, Karin Jirström

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer

    Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer de réir Mårten Lindén, Sara Bergström Lind, Corina Mayrhofer, Ulrika Segersten, Kenneth Wester, Yaroslav Lyutvinskiy, Roman A. Zubarev, Per‐Uno Malmström, Ulf Pettersson

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer

    Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer de réir Mervi Laakso, Minna Tanner, Jonas Nilsson, Tom Wiklund, Björn Erikstein, Pirkko Kellokumpu‐Lehtinen, Per‐Uno Malmström, Nils Wilking, Jonas Bergh, Jorma Isola

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer

    The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer de réir Tammer Hemdan, Mårten Lindén, Sara Bergström Lind, Arvind Venkat Namuduri, E. Sjöstedt, Teresita Díaz de Ståhl, Anna Asplund, Per‐Uno Malmström, Ulrika Segersten

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma

    Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma de réir Helena Nord, Ulrika Segersten, Johanna Sandgren, Kenneth Wester, Christer Busch, Uwe Menzel, Jan Komorowski, Jan P. Dumanski, Per‐Uno Malmström, Teresita Díaz de Ståhl

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)

    Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe) de réir Christel Häggström, Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Viveka Ströck, Abolfazl Hosseini, Truls Gårdmark, Amir Sherif, Per‐Uno Malmström, Hans Garmo, Staffan Jahnson, Lars Holmberg

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer

    Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer de réir Niels Fristrup, Karin Birkenkamp‐Demtröder, Thomas Reinert, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Joan Palou, M. Álvarez-Múgica, Chin‐Chen Pan, Benedicte Parm Ulhøi, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

    Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer de réir Niels Fristrup, Benedicte Parm Ulhøi, Karin Birkenkamp‐Demtröder, Francisco Mansilla, Marta Sänchez‐Carbayo, Ulrika Segersten, Per‐Uno Malmström, Arndt Hartmann, Joan Palou, M. Álvarez-Múgica, Karsten Zieger, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus

    Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus de réir Bernd J. Schmitz‐Dräger, Michael J. Droller, Vinata B. Lokeshwar, Yair Lotan, M’Liss A. Hudson, Bas W. van Rhijn, Michael Marberger, Yves Fradet, George P. Hemstreet, Per‐Uno Malmström, Osamu Ogawa, Pierre I. Karakiewicz, Shahrokh F. Shariat

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

    Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours de réir Moniek M. Vedder, Mirari Márquez, Esther W. de Bekker‐Grob, M. Luz Calle, Lars Dyrskjøt, Manoils Kogevinas, Ulrika Segersten, Per‐Uno Malmström, Ferrán Algaba, Willemien Beukers, Torben F. Ørntoft, Ellen C. Zwarthoff, Francisco X. Real, Núria Malats, Ewout W. Steyerberg

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

    Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy de réir Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin, Angelique Ziel‐van der Made, Kirstin A. van der Keur, Joost L. Boormans, Lars Dyrskjøt, Mirari Márquez, Torben F. Ørntoft, Francisco X. Real, Ulrika Segersten, Núria Malats, Per‐Uno Malmström, Wim Van Criekinge, Ellen C. Zwarthoff

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

    Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study de réir Lars Dyrskjøt, Karsten Zieger, Francisco X. Real, Núria Malats, Alfredo Carrato, Carolyn D. Hurst, S.A. Kotwal, Margaret A. Knowles, Per‐Uno Malmström, Manuel de la Torre, Kenneth Wester, Yves Allory, Dimitri Vordos, Aurélie Caillault, François Radvanyi, Anne-Mette K. Hein, Jens Ledet Jensen, Klaus Møller‐Ernst Jensen, Niels Marcussen, Torben F. Ørntoft

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer

    The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer de réir J. Alfred Witjes, Guido Dalbagni, R. Jeffrey Karnes, Shahrokh F. Shariat, Steven Joniau, Joan Palou, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Renzo Colombo, Marek Babjuk, Per‐Uno Malmström, Núria Malats, Jacques Irani, Jack Baniel, Tommaso Cai, K. Eugene, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Martin Spahn, Francesca Pisano, Paolo Gontero, Richard Sylvester

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018

    Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — up... de réir Yair Lotan, Trinity J. Bivalacqua, Tracy M. Downs, William C. Huang, Jeffrey A. Jones, Ashish M. Kamat, Badrinath R. Konety, Per‐Uno Malmström, James M. McKiernan, Michael A. O’Donnell, Sanjay Patel, Kamal S. Pohar, Matthew J. Resnick, Alexander Sankin, Angela Smith, Gary D. Steinberg, Edouard J. Trabulsi, Michael Woods, Siamak Daneshmand

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin

    The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guér... de réir Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Marco Oderda, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Bas van Rhijn, Alfred Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, Marek Babjuk, Viktor Soukup, Per‐Uno Malmström, Jacques Irani, Núria Malats, Jack Baniel, Roy Mano, Tommaso Cai, K. Eugene, Peter Ardelt, John Vakarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Évanguelos Xylinas, R. Jeffrey Karnes, Joan Palou

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups

    Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups de réir Kim E.M. van Kessel, Kirstin A. van der Keur, Lars Dyrskjøt, Ferrán Algaba, Naeromy Y.C. Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simić, Marcus Horstmann, Marc‐Oliver Grimm, Gregers G. Hermann, Karin Mogensen, Arndt Hartmann, Niels Harving, Astrid Petersen, Jørgen Bjerggaard Jensen, Kerstin Junker, Joost L. Boormans, Francisco X. Real, Núria Malats, Per‐Uno Malmström, Torben F. Ørntoft, Ellen C. Zwarthoff

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

    Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought de réir Joan Palou, Francesca Pisano, Richard Sylvester, Steven Joniau, Vincenzo Serretta, S. Larré, Savino M. Di Stasi, Bas van Rhijn, Alfred Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, M. Babjuk, Viktor Soukup, Per‐Uno Malmström, Jacques Irani, Núria Malats, Jack Baniel, Roy Mano, Tommaso Cai, K. Eugene, Peter Ardelt, John Varkarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Évanguelos Xylinas, R. Jeffrey Karnes, Paolo Gontero

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: